
Occidental Petroleum (OXY) announced the sale of its OxyChem petrochemical division to Berkshire Hathaway (BRKa) for $9.7 billion, a strategic divestiture aimed at significantly reducing OXY's substantial debt load, largely accumulated from its Anadarko and CrownRock acquisitions. OXY plans to allocate $6.5 billion of the proceeds to debt reduction, targeting a principal debt level below $15 billion, and signaling a refocus on its core oil and gas business. The transaction, which saw OXY shares rise 2.3% in premarket trading, further expands Berkshire's chemical holdings, leveraging its existing 27% stake in Occidental.
Occidental Petroleum's (OXY) sale of its OxyChem division to Berkshire Hathaway for $9.7 billion is a pivotal step in its deleveraging strategy. The all-cash deal directly addresses the substantial debt load, which stood at $23.34 billion by the end of June, primarily accumulated from the $55 billion Anadarko acquisition in 2019 and the more recent $12 billion CrownRock purchase. By allocating $6.5 billion of the proceeds to debt reduction, Occidental is set to bring its principal debt below its stated $15 billion target, a significant milestone that evidently resonated with the market, as reflected by the 2.3% premarket share price increase. This divestiture, which sheds a unit that generated $2.42 billion in revenue in the first half of the year, also marks a strategic refocus on the company's core oil and gas business, which constituted 75% of its earnings last year. For Berkshire Hathaway, already Occidental's largest shareholder with a 27% stake, the acquisition expands its chemical holdings and represents its largest transaction since the 2022 Alleghany purchase, signaling strong confidence in the underlying value of the assets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.65
Ticker Sentiment